Poland · Delayed Price · Currency is PLN Genomed Spólka Akcyjna Statistics
Total Valuation
WSE:GEN has a market cap or net worth of PLN 34.09 million. The enterprise value is 28.56 million.
| Market Cap | 34.09M |
| Enterprise Value | 28.56M |
Important Dates
The next confirmed earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
WSE:GEN has 1.32 million shares outstanding.
| Current Share Class | 648,283 |
| Shares Outstanding | 1.32M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 44.76% |
| Owned by Institutions (%) | n/a |
| Float | 44,349 |
Valuation Ratios
The trailing PE ratio is 11.10.
| PE Ratio | 11.10 |
| Forward PE | n/a |
| PS Ratio | 1.15 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | 18.34 |
| P/OCF Ratio | 10.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.13, with an EV/FCF ratio of 15.37.
| EV / Earnings | 9.30 |
| EV / Sales | 0.97 |
| EV / EBITDA | 6.13 |
| EV / EBIT | 7.40 |
| EV / FCF | 15.37 |
Financial Position
The company has a current ratio of 8.18
| Current Ratio | 8.18 |
| Quick Ratio | 6.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 844.72 |
Financial Efficiency
Return on equity (ROE) is 24.55% and return on invested capital (ROIC) is 37.46%.
| Return on Equity (ROE) | 24.55% |
| Return on Assets (ROA) | 17.04% |
| Return on Invested Capital (ROIC) | 37.46% |
| Return on Capital Employed (ROCE) | 26.74% |
| Weighted Average Cost of Capital (WACC) | 4.75% |
| Revenue Per Employee | 528,265 |
| Profits Per Employee | 54,848 |
| Employee Count | 56 |
| Asset Turnover | 2.09 |
| Inventory Turnover | 5.92 |
Taxes
In the past 12 months, WSE:GEN has paid 763,936 in taxes.
| Income Tax | 763,936 |
| Effective Tax Rate | 19.92% |
Stock Price Statistics
The stock price has decreased by -0.77% in the last 52 weeks. The beta is 0.09, so WSE:GEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -0.77% |
| 50-Day Moving Average | 25.37 |
| 200-Day Moving Average | 26.47 |
| Relative Strength Index (RSI) | 53.66 |
| Average Volume (20 Days) | 36 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSE:GEN had revenue of PLN 29.58 million and earned 3.07 million in profits. Earnings per share was 2.32.
| Revenue | 29.58M |
| Gross Profit | 19.52M |
| Operating Income | 3.86M |
| Pretax Income | 3.84M |
| Net Income | 3.07M |
| EBITDA | 4.66M |
| EBIT | 3.86M |
| Earnings Per Share (EPS) | 2.32 |
Balance Sheet
The company has 5.53 million in cash and n/a in debt, with a net cash position of 5.53 million or 4.18 per share.
| Cash & Cash Equivalents | 5.53M |
| Total Debt | n/a |
| Net Cash | 5.53M |
| Net Cash Per Share | 4.18 |
| Equity (Book Value) | 14.07M |
| Book Value Per Share | 10.65 |
| Working Capital | 9.72M |
Cash Flow
In the last 12 months, operating cash flow was 3.28 million and capital expenditures -1.43 million, giving a free cash flow of 1.86 million.
| Operating Cash Flow | 3.28M |
| Capital Expenditures | -1.43M |
| Depreciation & Amortization | 796,299 |
| Net Borrowing | n/a |
| Free Cash Flow | 1.86M |
| FCF Per Share | 1.41 |
Margins
Gross margin is 65.99%, with operating and profit margins of 13.05% and 10.38%.
| Gross Margin | 65.99% |
| Operating Margin | 13.05% |
| Pretax Margin | 12.97% |
| Profit Margin | 10.38% |
| EBITDA Margin | 15.74% |
| EBIT Margin | 13.05% |
| FCF Margin | 6.28% |
Dividends & Yields
WSE:GEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 9.01% |
| FCF Yield | 5.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
WSE:GEN has an Altman Z-Score of 15.97 and a Piotroski F-Score of 7.
| Altman Z-Score | 15.97 |
| Piotroski F-Score | 7 |